Accuray (ARAY) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,111.00 |
| Dec 31, 2025 | -3,908.00 |
| Sep 30, 2025 | 1,640.00 |
| Mar 31, 2025 | 2,090.00 |
| Dec 31, 2024 | -1,516.00 |
| Sep 30, 2024 | 2,128.00 |
| Mar 31, 2024 | -1,675.00 |
| Dec 31, 2023 | 319.00 |
| Sep 30, 2023 | -1,973.00 |
| Mar 31, 2023 | 19.00 |
| Dec 31, 2022 | -1,415.00 |
| Sep 30, 2022 | 1,522.00 |
| Mar 31, 2022 | 1,222.00 |
| Dec 31, 2021 | 3,432.00 |
| Sep 30, 2021 | -11,448.00 |
| Mar 31, 2021 | 4,052.00 |
| Dec 31, 2020 | 1,418.00 |
| Sep 30, 2020 | -1,598.00 |
| Jun 30, 2020 | 54,182.00 |
| Mar 31, 2020 | -1,100.00 |
| Dec 31, 2019 | 1,511.00 |
| Sep 30, 2019 | -777.00 |
| Jun 30, 2019 | -101.00 |
| Mar 31, 2019 | -1,924.00 |
| Dec 31, 2018 | -835.00 |
| Sep 30, 2018 | -140.00 |
| Jun 30, 2018 | 1,993.00 |
| Mar 31, 2018 | 3,352.00 |
| Dec 31, 2017 | 4,008.00 |
| Sep 30, 2017 | 699.00 |
| Jun 30, 2017 | 2,788.00 |
| Mar 31, 2017 | -1,512.00 |
| Dec 31, 2016 | -1,448.00 |
| Sep 30, 2016 | 4,077.00 |
| Jun 30, 2016 | -17,539.00 |
| Mar 31, 2016 | 808.00 |
| Dec 31, 2015 | -1,075.00 |
| Sep 30, 2015 | 4,237.00 |